• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UVaDOCCommunitiesBy Issue DateAuthorsSubjectsTitles

    My Account

    Login

    Statistics

    View Usage Statistics

    Share

    View Item 
    •   UVaDOC Home
    • SCIENTIFIC PRODUCTION
    • Departamentos
    • Dpto. Medicina, Dermatología y Toxicología
    • DEP52 - Artículos de revista
    • View Item
    •   UVaDOC Home
    • SCIENTIFIC PRODUCTION
    • Departamentos
    • Dpto. Medicina, Dermatología y Toxicología
    • DEP52 - Artículos de revista
    • View Item
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Export

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/5862

    Título
    Levels of DKK1 in patients with acute myocardial infarction and response to atorvastatin
    Autor
    Pérez Castrillon, José LuisAutoridad UVA
    San Miguel, Ángel
    Vega, Gemma
    Abad Manteca, LauraAutoridad UVA
    Andrés Domingo, María
    González Sagrado, ManuelAutoridad UVA
    Luis Román, Daniel Antonio deAutoridad UVA Orcid
    Dueñas Laita, AntonioAutoridad UVA
    Año del Documento
    2009
    Editorial
    Elsevier Ireland Ltd.
    Descripción
    Producción Científica
    Documento Fuente
    International Journal of Cardiology, 2009, p. 164-165
    Abstract
    The atherosclerosis that appears in coronary, cerebrovascular and peripheral arterial disease is responsible for most cardiovascular diseases. It is characterized by chronic arterial inflammation caused and exacerbated by disorders of the lipidic metabolism and other clearly identified risk factors [1]. Calcification, which is initiated by an active process in which inflammatory cytokines and other mediators that regulate the phospho-calcium metabolism intervene, is characteristic of atherosclerosis [2]. These mechanisms can intervene in an opposite phenomenon that takes place at the level of the bone characterized by a reduction in bone mineral content and alterations in the microarchitecture that define osteoporosis. The association between the two diseases, which share mechanisms but have a different expression, is noteworthy.
    Materias (normalizadas)
    Arteriosclerosis - Tratamiento
    Cardiovascular, Aparato - Enfermedades
    ISSN
    0167-5273
    Revisión por pares
    SI
    DOI
    10.1016/j.ijcard.2009.07.025
    Idioma
    eng
    URI
    http://uvadoc.uva.es/handle/10324/5862
    Derechos
    openAccess
    Collections
    • DEP52 - Artículos de revista [181]
    Show full item record
    Files in this item
    Nombre:
    CASTRILLON 13[1].pdf
    Tamaño:
    63.30Kb
    Formato:
    Adobe PDF
    Descripción:
    PD-86
    Thumbnail
    FilesOpen
    Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcept where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10